Human skin fibroblasts as a model of growth hormone (GH) action in GH receptor-positive Laron's syndrome

Endocrinology

Volumn 138, Issue 1, 1997, Pages 55-61

  Freeth, James S ^a   Ayling, Ruth M ^b   Whatmore, Andrew J ^a   Towner, Paul ^b   Price, D Anthony ^a   Norman, Michael R ^c   Clayton, Peter E ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RECEPTOR; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 3;

ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GROWTH HORMONE RELEASE; HORMONE RESISTANCE; HUMAN; HUMAN CELL; LARON SYNDROME; PRIORITY JOURNAL; SHORT STATURE; SIGNAL TRANSDUCTION; SKIN FIBROBLAST;

EID: 0031014897     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.1.4853     Document Type: Article

References (43)

1. Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J 1994 Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 15:369-390
2. Leung DW, Spencer SA, Cachianes G, Hammonds GR, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI 1987 Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330:537-543
3. Trivedi H, Daughaday WH 1988 Release of growth hormone binding protein from IM-9 lymphocytes by endopeptidase is dependent on sulfydryl group inactivation. Endocrinology 123:2201-2206
4. Aguirre A, Donnadieu M, Job J-C, Chassain J-L 1990 Nanisme de type Laron: hétérogénéité de l'anomalie biochimique chez trois enfants et leurs parents. C R Acad Sci [D] (Paris) 311:315-319
5. Buchanan CR, Maheshwari HG, Norman MR, Morrell DJ, Preece MA 1991 Laron-type dwarfism with apparently normal high affinity serum growth hormone-binding protein. Clin Endocrinol (Oxf) 35:179-185
6. Savage MO, Blum WF, Ranke MB, Postel-Vinay MC, Cotterill AM, Hall K, Chatelain PG, Preece MA, Rosenfeld RG 1993 Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). J Clin Endocrinol Metab 77:1465-1471
7. Duquesnoy P, Sobrier M-L, Duriez B, Dastot F, Buchanan CR, Savage MO, Preece MA, Craescu CT, Blouquit Y, Goossens M, Amselem S 1994 A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerisation. EMBO J 13:1386-1395
8. Woods KA, Fraser NC, Postel-Vinay M-C, Savage MO, Clark AJL 1996 A homozygous splice-site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein. J Clin Endocrinol Metab 81:1686-1690
9. Barnard R, Ng KW, Martin TJ, Waters MJ 1991 Growth hormone receptors in clonal osteoblast-like cells mediate a mitogenic response to growth hormone. Endocrinology 128:1459-1464
10. DiGirolamo M, Eden S, Enberg G, Isaksson O, Lonnroth P, Hall K, Smith U 1986 Specific binding of human growth hormone but not insulin-like growth factors by human adipocytes. FEBS Lett 205:15-19
11. Kiess W, Butenandt O 1985 Specific growth hormone receptors on human peripheral mononuclear cells: reexpression, identification and characterization. J Clin Endocrinol Metab 60:740-746
12. Murphy J, Vrhovsek E, Lazarus L 1983 Identification and characterisation of specific growth hormone receptors in cultured human fibroblasts. J Clin Endocrinol Metab 57:1117-1124
13. Oakes SR, Haynes KM, Waters MJ, Herrington AC, Werther GA 1992 Demonstration and localisation of growth hormone receptor in human skin and skin fibroblasts. J Clin Endocrinol Metab 75:1368-1373
14. Tavakkol A, Elder JT, Griffiths CEM, Cooper KD, Talwar H, Fisher GJ, Keane KM, Foltin SK, Voorhees JJ 1992 Expression of growth hormone receptor, insulin-like growth factor-1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J Invest Dermatol 99:343-349
15. Cook JJ, Haynes KM, Werther GA 1988 Mitogenic effects of growth hormone in cultured human fibroblasts. J Clin Invest 81:206-212
16. Conover CA, Liu F, Powell D, Rosenfeld RG, Hintz RL 1989 Insulin-like growth factor binding proteins from cultured human fibroblasts. J Clin Invest 83:852-859
17. Camancho-Hubner C, Busby Jr WH, McCusker RH, Wright G, Clemmons DR 1992 Identification of the forms of insulin-like growth factor binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J Biol Chem 267:11949-11956
18. Martin JL, Coverley JA, Baxter RC 1994 Regulation of immunoreactive insulin-like growth factor binding protein-6 in normal and transformed human fibroblasts. J Biol Chem 269:11470-11477
19. Schmid C, Schläpfer I, Waldvogel M, Peter M, Zapf PJ, Froesch ER 1993 Production of IGFBP-3 by connective tissue and endothelial cells. Growth Regul 3:65-67
20. McGraw ME, Price DA, Hill DJ 1986 Somatomedin C deficiency in Asian sisters. Arch Dis Child 61:1233-1235
21. Lench N, Stainer P, Williamson R 1988 Simple non-invasive method to obtain DNA for gene analysis. Lancet 1:1356-1358
22. Amselem S, Duquesnoy P, Attree O, Novelli G, Bousnina S, Postel-Vinay M-C, Goossens M 1989 Laron dwarfism and mutations of the growth hormone-receptor gene. N Engl J Med 321:989-995
23. Hossenlopp P, Seurin D, Seqovia-Quinson B, Hardouin S, Binoux M 1986 Analysis of serum insulin-like growth factor binding proteins using western blotting. Use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154:138-143
24. Gill MS, White A, Whatmore AJ, Price DA, Clayton PE 1995 Serum and urine insulin-like growth factor binding protein-3: relationship to urinary growth hormone in children with disordered growth. J Endocrinol [Suppl] 147:O33
25. Baxter RC, Martin JL 1986 Radioimmunoassay of growth hormone-dependent inusulinlike growth factor binding protein in human plasma. J Clin Invest 78:1504-1512
26. Powell SM, Petersen GM, Krush AJ, Booker S, Jen J, Giardiello FM, Hamilton SR, Vogelstein B, Kinzler KW 1993 Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 329:1982-1987
27. Urbanek M, Russell JE, Cooke NE, Liebhaber SA 1993 Functional characterisiation of the alternatively spliced, placental human growth hormone receptor. J Biol Chem 268:19025-19032
28. Bass SH, Mulkerrin MG, Wells JA 1991 A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor. Proc Natl Acad Sci USA 88:4498-4502
29. Urbanek M, MacLeod JN, Cooke NE, Liebhaber SA 1992 Expression of a human growth hormone (GH) receptor isoform is predicted by tissue-specific alternative splicing of exon 3 of the hGH receptor gene transcript. Mol Endocrinol 6:279-287
30. Sobrier M-L, Duquesnoy P, Duriez B, Amselem S, Goossens M 1993 Expression and binding properties of two isoforms of the human growth hormone receptor. FEBS Lett 319:16-20
31. Wickelgren RB, Landin KLL, Ohlsson C, Carlsson LMS 1995 Expression of exon 3-retaining and exon 3-excluding isoforms of the human growth hormone-receptor is regulated in an individual, rather than a tissue-specific, manner. J Clin Endocrinol Metab 80:2154-2157
32. Faase E, Brown MR, Meacham LR, Abdul-Latif H, Klinger B, Laron Z, Parks JS, Deletion of exon 3 of the growth hormone receptor gene in Laron syndrome families. 76th Annual Meeting of The Endocrine Society, Anaheim CA, 1994, p 1636 (Abstract)
33. Geffner ME, Golde DW, Lippe BM, Kaplan SA, Bersch N, Li CH 1987 Tissues of the Laron dwarf are sensitive to insulin-like growth factor I but not to growth hormone. J Clin Endocrinol Metab 64:1042-1046
34. Giannini S, Mohan S, Kasuya J, Galli G, Rotella CM, LeBon TR, Fujita-Yamaguichi Y 1994 Characterisation of insulin-like growth factor-binding proteins produced by cultured fibroblasts from patients with noninsulin-dependent diabetes mellitus, insulin-dependent diabetes mellitus, or obesity. J Clin Endocrinol Metab 79:1824-1830
35. Oakes SR, Haynes KM, Batch J, Ennis G, Waters MJ, Daughaday W, Herrington AC, Werther GA 1994 Immunoreactive growth hormone receptor/binding protein is present on fibroblasts and in serum of Laron-type dwarfs. Mol Cell Endocrinol 99:125-132
36. Whatmore AJ, Freeth JS, Price DA, Addison GM, Clayton PE 1994 Growth hormone binding and growth hormone receptor complex formation in human foetal fibroblasts compared with Swiss 3T3 fibroblasts. J Endocrinol [Suppl] 140:P187
37. Vaccarello MA, Rosenbloom AL, Guevara-Aguirre J, Shiverick KT, Comparison of biological responses in Ecuadorian Laron syndrome (LS) and normal skin fibroblasts to GH, IGF-I, and insulin. 76th Annual Meeting of The Endocrine Society, Anaheim CA, 1994, p 1635 (Abstract)
38. Eshet R, Duz Z, Silbergeld A, Koren R, Klinger B, Laron Z 1991 Erythrocytes from patients with low serum concentrations of IGF-I have an increase in receptor sites for IGF-I. Acta Endocrinol (Copenh) 125:354-358
39. Blum WF, Cotterill AM, Postel-Vinay MC, Ranke MB, Savage MO, Wilton P 1994 Improvements of diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfalls. Acta Pediatr [Suppl] 399:117-124
40. Bale LK, Conover CA 1992 Regulation of insulin-like growth factor binding protein-3 messenger ribonucleic acid expression by insulin-like growth factor I. Endocrinology 131:608-614
41. Schmid C, Schläpfer I, Peter M, Böni-Schnetzler M, Schwander J, Zapf J, Froesch ER 1994 Growth hormone and parathyroid hormone stimulate IGFBP-3 in rat osteoblasts. Am J Physiol 267:E226-E233
42. De W, Bréant B, Czernichow P, Asfari M 1995 Growth hormone (GH) and prolactin (PRL) regulate IGFBP-3 gene expression in rat β-cells. Mol Cell Endocrinol 114:43-50
43. Postel-Vinay M-C, Finidori J 1995 Growth hormone receptor: structure and signal transduction. Eur J Endocrinol 133:654-659